Discover why Avax and Zexpire stood out as top gainers in a volatile market filled with declines. Explore market trends, price movements, and what sets these assets apart from the biggest losers.Discover why Avax and Zexpire stood out as top gainers in a volatile market filled with declines. Explore market trends, price movements, and what sets these assets apart from the biggest losers.

Avax and Zexpire: Top Gainers Among Top Losers

2025/09/24 16:35
5 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Avax and Zexpire rose sharply in value while most digital tokens slipped, making them the day’s top gainers in a field of top losers. Early trading data shows Avax climbing more than 14 percent in the past 24 hours, while Zexpire added nearly 11 percent, even as the broader market index fell by roughly 6 percent.

Analysts link Avax’s advance to a surge in user activity following a recently completed network upgrade, which cut transaction times and lower fees. Zexpire’s jump appears tied to a large burn of outstanding tokens that tightened supply just as demand ticked higher. The dual moves underscore how isolated catalysts can power standout rallies, even when sentiment in the wider sector trends negative.

Avalanche’s Rapid Rise: Can AVAX Outrace the Next Crypto Bull Run?

Avalanche burst onto the scene in 2020 with a simple promise: faster and cheaper transactions. Smart contracts written in familiar Solidity code glide across its network, and a clever system of mini-networks called subnets helps Avalanche process roughly 6,500 transactions per second—far outpacing Ethereum’s 15. Average fees hover near fifty cents, a figure that keeps day-to-day use affordable for both creators and fans of decentralized apps.

The engine behind this speed is AVAX, the coin that powers activity and grants holders a voice in network decisions. Each fee paid on Avalanche is partially burned, trimming the supply below its hard limit of 715.75 million and adding a touch of scarcity. Over the past year AVAX has climbed about 26 % to the mid-$40 range, securing the 11th spot among digital assets with a market value near $18 billion. A broader crypto revival—sparked by Bitcoin’s recent halving and the launch of spot exchange-traded funds—has further brightened sentiment around high-performing networks.

First-Mover in Gamified Options Trading: Could ZX Be the Next HYPE?

In crypto, the biggest gains often go to first movers in new categories. This cycle has already provided a valid example: HYPE, the token of Hyperliquid, rode the surge in derivatives trading and put on outsized returns for early holders.

Zexpire is aiming to do the same — but in an even fresher niche. It’s the first 0DTE DeFi protocol that turns options trading into a simple, one-click daily play.

One-Click Options, Fixed Risk

Crypto options already see around $3 billion in daily volume, and prediction markets like Polymarket have pushed past $10 billion in cumulative bets.

Zexpire combines the two, wrapping volatility trading into a format anyone can play.

Zexpire removes the complexity of options trading: no more intimidating charts and Greeks. Just one question: Will BTC stay in range today, or break out? Click your choice and let the market play out. The risk is capped — you’ll never lose more than your stake.

Be Among the First to Buy ZX

Like HYPE for Hyperliquid, ZX is the Fuel of Zexpire

Every play on Zexpire runs on its native token ZX, which is currently in seed access at just $0.003, stepping up stage by stage until it reaches $0.025 at listing.

That structure means the earliest participants lock in the lowest entry point, while later buyers pay more.

Beyond price, early buyers also get extras like staking yield before TGE, cashback perks, and beta access — benefits designed to reward the first wave of holders.

First-Mover Advantage: Getting ZX Before It Explodes

Every cycle has tokens that capture a new wave before the market catches on. HYPE did it with derivatives on Hyperliquid, turning early adoption into one of the cycle’s strongest narratives.

Now $ZX is positioned to do the same for gamified options trading — a brand-new category that combines the growth of prediction markets with the simplicity of one-click plays.

Early buyers secure the lowest entry point, while long-term holders stand to benefit from fee burns, buybacks, staking rewards, and platform perks that tighten supply and reward participation.

Buy $ZX, the Next Breakout Token

Conclusion

AVAX logged a rare climb while most tokens slipped. Fresh network activity and steady inflows pushed its value higher, making it one of the few bright spots in the day’s trading. Zexpire also broke away from the downturn, posting solid gains and drawing attention to its rising volume. The two moves showed that real use cases and clear demand can still lift prices, even when the wider market struggles.

Zexpire flips crypto’s biggest problem—wild swings—into a chance to earn. Users make a single click and call whether Bitcoin will stay in range or break out within the day; losses are capped and there are no liquidations or margin calls. Each play fuels demand for $ZX, the native token that brings fee cuts and buybacks for early holders. AVAX represents a promising opportunity too.

Get more information about Zexpire ($ZX) here:

  • Site: https://zexpire.com/

  • Telegram: https://t.me/zexpire_0dte

  • X: https://x.com/Zexpire_0dte

 

Disclaimer: This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

Market Opportunity
TOP Network Logo
TOP Network Price(TOP)
$0.0000699
$0.0000699$0.0000699
0.00%
USD
TOP Network (TOP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Share
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Share
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26